Combining intensity-modulated radiotherapy (IMRT) with chemotherapy to treat locally advanced oropharyngeal (head and neck) cancer improves long-term health-related quality of life (HRQOL) outcomes, according to a University of Michigan study. The research shows this approach spares the swallowing and salivary organs.
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now